FLKS FLEX PHARMA INC

Flex Pharma to Report Third Quarter 2016 Results on November 2, 2016

BOSTON--(BUSINESS WIRE)--

Click to Tweet

Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), cramps and spasms associated with severe neuromuscular conditions such as MS and ALS, and exercise-associated muscle cramps, announced today that it will report its financial results for the third quarter ended September 30, 2016 on Wednesday, November 2, 2016 before the U.S. financial markets open. The Company will host a conference call and webcast at 8:45 a.m. ET to discuss third quarter 2016 financial results and provide a business update. Individuals interested in participating in the call should dial (855) 780-7202 (U.S. and Canada) or (631) 485-4874 (International).

A live webcast may be accessed in the Investors section of the Company's website at www.flex-pharma.com. Please log on to the Flex Pharma website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Flex Pharma's website for three months.

About Flex Pharma

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps, cramps and spasms associated with severe neuromuscular conditions such as MS and ALS, and exercise-associated muscle cramps. Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.

Visit www.TeamHOTSHOT.com for updates and to learn more about HOTSHOT™, the Company’s consumer product which is scientifically proven to prevent and treat muscle cramps.

HOTSHOT is a consumer product that is marketed to endurance athletes for exercise-associated muscle cramps. HOTSHOT complements the Company’s drug development business and is not intended to diagnose, treat, cure or prevent any disease.

Follow Flex Pharma (@flexpharma) and HOTSHOTTM (@Team_HOTSHOT) on Twitter

EN
26/10/2016

Underlying

FLKSFLEX PHARMA INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on FLEX PHARMA INC

Jonathan Moreland
  • Jonathan Moreland
Free Trial
RPM RPM INTERNATION...
WIRE Encore Wire Cor... ... (+59)

InsiderInsights Weekly Tables: October 20, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

RPM RPM INTERNATIONAL INC.
WIRE ENCORE WIRE CORPORATION
VSTM VERASTEM INC
TCBI TEXAS CAPITAL BANCSHARES INC.
SPKE SPARK ENERGY INC-CLASS A
PSA PUBLIC STORAGE
PRGX PRGX GLOBAL
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
KMPH KEMPHARM INC
58I1 INTREPID POTASH INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
HY HYSTER-YALE MATERIALS HANDLING INC. CLASS A
HBI HANESBRANDS INC.
FRED FRED'S INC.
FLKS FLEX PHARMA INC
FLDM FLUIDIGM
FDX FEDEX CORPORATION
FATE FATE THERAPEUTICS INC
FAST FASTENAL COMPANY
DLTR DOLLAR TREE INC.
CRMD CORMEDIX INC.
BDGE BRIDGE BANCORP INC.
GNK GENCO SHIPPING & TRADING LTD.
MLVF MALVERN BANCORP
JMP JMP GROUP LLC
BSET BASSETT FURNITURE INDUSTRIES INC.
CERC CERECOR INC
DSPG DSP GROUP INC.
FBHS
ITI FORTUNE BRANDS HOME & SECURITY INC.
THO ITERIS
ARDC THOR INDUSTRIES INC.
AIRT ARES DYNAMIC CREDIT ALLOCATION
FSBW AIR T INC.
CNBKA FS BANCORP INC
NOVN CENTURY BANCORP INC. CL A
ASPU NOVAN INC
MEET ASPEN GROUP INC
RGRX MEET GROUP
FEIM REGENERX BIOPHARMACEUTICALS INC
KALA FREQUENCY ELECTRONICS INC.
ATNX KALA PHARMACEUTICALS INC.
APPN ATHENEX
ROSE APPIAN
MMAC ROSEHILL RESOURCES
MTEM MMA CAPITAL MANAGEMENT
BBDC LLC
FPAY VOIP INC.
SLCA BARINGS BDC INC.
FUND FLEXSHOPPER
PDI U.S. SILICA HOLDINGS
PCI INC.
AMRK ROYCE FOCUS TRUST
PLAG INC.
PIMCO DYNAMIC INCOME FUND
PIMCO DYNAMIC CREDIT INCOME FUND
A-MARK PRECIOUS METALS
INC.
PLANET GREEN HOLDINGS (N SHARES)
10/20/18 October 20, 2018 15 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
RPM RPM INTERNATION...
LTS Ladenburg Thalm... ... (+12)

InsiderInsights Daily Ratings Report: October 18, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

RPM RPM INTERNATIONAL INC.
LTS LADENBURG THALMANN FINANCIAL SERVICES INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
FLKS FLEX PHARMA INC
FDX FEDEX CORPORATION
ITI ITERIS
SSP THE E.W. SCRIPPS COMPANY
MMAC MMA CAPITAL MANAGEMENT
PLAG LLC
RGT PLANET GREEN HOLDINGS (N SHARES)
ROYCE GLOBAL VALUE TRUST
INC.
10/19/18 October 19, 2018 3 EN
 PRESS RELEASE
Free
FLKS FLEX PHARMA INC

Flex Pharma Reports First Quarter 2018 Financial Results

BOSTON--(BUSINESS WIRE)-- Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for muscle cramps, spasms and spasticity associated with severe neurological diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) under FDA Fast Track designation, and Charcot-Marie-Tooth (CMT) neuropathy, today reported financial results for the quarter ended March 31, 2018 and provided an update on its clini...

May 2, 2018 1 EN
 PRESS RELEASE
Free
FLKS FLEX PHARMA INC

Flex Pharma to Report First Quarter 2018 Financial Results on May 2, 2...

BOSTON--(BUSINESS WIRE)-- Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and spasticity associated with severe neurological diseases such as multiple sclerosis (MS), Charcot-Marie-Tooth (CMT) and amyotrophic lateral sclerosis (ALS) under FDA Fast Track designation, announced today that it will report its financial results for the first quarter ended March 31, 2018 on Wednesday, May 2, 2018 before the U.S. financial markets open. The Co...

April 25, 2018 1 EN
 PRESS RELEASE
Free
FLKS FLEX PHARMA INC

Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Tri...

BOSTON--(BUSINESS WIRE)-- Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps, spasms and spasticity associated with severe neurological diseases such as multiple sclerosis (MS), Charcot-Marie-Tooth (CMT) and amyotrophic lateral sclerosis (ALS) under FDA Fast Track designation today announced positive topline data for FLX-787 from its exploratory Phase 2 trial in MS patients with frequent muscle cramps/spasms and spasticity. “MS pat...

March 26, 2018 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch